Vimarsana
Biggest News Aggregation in the World

Page 38 - Ryan Weispfenning News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ryan Weispfenning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ryan Weispfenning Today - Breaking & Trending Today

Medtronic self-expanding TAVR platform shows excellent longer-term performance at five years in SURTAVI Trial - Vimarsana News

Medtronic self-expanding TAVR platform shows excellent longer-term performance at five years in SURTAVI Trial

Published: November 5, 2021

TCT 2021: Intermediate risk TAVR patients demonstrate strong hemodynamics and stable valve performance at five years Medtronic plc a global leader in healthcare technology, today unveiled five-year clinical data from the Surgical Replacement and Transcatheter Aortic Valve Implantation Trial, which was presented as a Late Breaking Clinical Trial at the 33 rd Transcatheter Cardiovascular Therapeutics conference, the ...

Source: investingnews.com
Related Topics:
Nicolas Van MieghemCorevalve EvolutMichael ReardonMedtronic CorevalveRyan WeispfenningJoey LomickyExchange CommissionErasmus University Medical CenterOur MissionCardiovascular Research FoundationSurgical ReplacementTranscatheter Aortic Valve ImplantationLate Breaking Clinical TrialTranscatheter Cardiovascular TherapeuticsCardiovascular ResearchAllison Family Distinguished ChairHouston Methodist Debakey HeartVascular CenterErasmus UniversityMedical Center
Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option - Vimarsana News

Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option

Published: November 4, 2021

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Related Topics:
New YorkUnited StatesJason WeidmanMedtronic Symplicity SpyralSymplicity SpyralMichael WeberColl CardiolPrnewswire MedtronicRyan WeispfenningMedtronic SymplicityKrystin Hayward LeongEuropean Society Of HypertensionDownstate Medical CenterDrug AdministrationSociety For Cardiovascular AngiographyExchange CommissionNational Kidney FoundationUniversity Of New YorkPiedmont Heart Institute In AtlantaGlobal Clinical ProgramOur MissionCardiovascular Research FoundationMedtronic Patient PreferencePatient PreferencesInterventional Hypertension
Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option - Vimarsana News

Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option

Published: November 4, 2021

/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced findings from a new study of the Patient Preferences for...

Source: prnewswire.com
Related Topics:
New YorkUnited StatesJason WeidmanMedtronic Symplicity SpyralSymplicity SpyralMichael WeberColl CardiolRyan WeispfenningMedtronic SymplicityKrystin Hayward LeongEuropean Society Of HypertensionDownstate Medical CenterDrug AdministrationSociety For Cardiovascular AngiographyExchange CommissionNational Kidney FoundationUniversity Of New YorkPiedmont Heart Institute In AtlantaGlobal Clinical ProgramOur MissionCardiovascular Research FoundationMedtronic Patient PreferencePatient PreferencesInterventional HypertensionTranscatheter Cardiovascular Therapeutics
Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option - Vimarsana News

Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option

Published: November 4, 2021

/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced findings from a new study of the Patient Preferences for...

Source: prnewswire.com
Related Topics:
New YorkUnited StatesJason WeidmanMedtronic Symplicity SpyralSymplicity SpyralMichael WeberColl CardiolRyan WeispfenningMedtronic SymplicityKrystin Hayward LeongEuropean Society Of HypertensionDownstate Medical CenterDrug AdministrationSociety For Cardiovascular AngiographyExchange CommissionNational Kidney FoundationUniversity Of New YorkPiedmont Heart Institute In AtlantaGlobal Clinical ProgramOur MissionCardiovascular Research FoundationMedtronic Patient PreferencePatient PreferencesInterventional HypertensionTranscatheter Cardiovascular Therapeutics
Rune Labs and Medtronic Partner to Evaluate Use of Medtronic BrainSense™ Data in Rune's Software for Precision Neurology - Vimarsana News

Rune Labs and Medtronic Partner to Evaluate Use of Medtronic BrainSense™ Data in Rune's Software for Precision Neurology

Published: November 2, 2021

/PRNewswire/ -- Rune Labs, a company using aggregated brain data to empower the development and delivery of precision medicines for neurological and...

Source: prnewswire.com
Related Topics:
Brian PepinLindsey DickinsonRyan WeispfenningRob RaikeExchange CommissionRune Labs IncOur MissionDistinguished ScientistRune LabsApple Watch